---
title: 'Joint PSI, EFSPI and ASA BIOP Webinar - Complex Innovative Designs'
author: ''
date: '2021-10-21T06:00:00-07:00'
slug: joint-psi-efspi-asa-biop-webinar-complex-innovative-designs
categories: 
tags: 
  - Innovative Designs
  - PSI
  - ASA
type: webinar
url_register: ~
url_freeregister: https://www.psiweb.org/events/event-item/2021/10/21/default-calendar/joint-psi-efspi-asa-biop-webinar-complex-innovative-designs
url_slides: ~
url_video: https://www.psiweb.org/vod/item/joint-psi-efspi-asa-biop-webinar-complex-innovative-designs
url_agenda: ~
url_website: https://www.psiweb.org/vod/item/joint-psi-efspi-asa-biop-webinar-complex-innovative-designs
url_audio: ~
url_code: ~
url_pdf: ~
date_end: '2021-10-21T08:00:00-07:00'
all_day: no
publishDate: '2021-09-27T11:15:07-07:00'
authors: []
featured: no
image:
  caption: ''
  focal_point: ''
  preview_only: no
slides: ''
projects: []
location: ~
address:
  street: ~
  city: ~
  region: ~
  postcode: ~
  country: ~
summary: ~
abstract: ~
speaker: John Scott (FDA) | Olivier Collignon (GSK) | Dieter Häring (Novartis) | Marius Thomas (Novartis)
---
<!--more-->
PSI, the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmaceutical Section of the American Statistical Association (ASA) are jointly organising a webinar on Complex Innovative Designs (CID) in practice.  Speakers from regulatory authorities and industry will present on their experience, which will include the following aspects:  
 
- Overview of the FDA Complex Innovative Trial Design pilot program and the applications received to date together with details on some of them  
- Overview of the FDA guidance on interacting on Complex Innovative Trial Designs  
- Detailed case study of a clinical trial in children which was evaluated within FDA’s CID pilot program, applying borrowing of information from external trials in adults  
- Overview of statistical and regulatory considerations on master protocols, focusing on Phase III confirmatory trials.  